Elevation Oncology Terminates License Agreement With CSPC Megalith Biopharmaceutical

Reuters
2025.07.02 20:20
July 2 (Reuters) - Elevation Oncology Inc (ELEV.O) : * ELEVATION ONCOLOGY INC -LICENSE AGREEMENT WITH CSPC MEGALITH BIOPHARMACEUTICAL TERMINATED AS OF JUNE 26, 2025 - SEC FILING * ELEVATION ONCOLOGY INC - TERMINATION AGREEMENT INCLUDES MUTUAL RELEASE OF CLAIMS - SEC FILING Further company coverage: (ELEV.O)
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer